Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Financial Other
confidence 85%
filed 2026-06-22
Item 7.01
This Item 7.01 Regulation FD Disclosure furnishes investor materials containing Toyota Motor Credit Corporation's financial results for fiscal 2026, including consolidated net income of $2.3 billion, provision for credit losses of $524 million, and detailed operational metrics for Toyota U.S. vehicle sales and financing volumes. While the disclosure includes financial performance data, it does not constitute a formal earnings release (which would typically be filed as an exhibit under Item 2.02) but rather supplemental business highlights and investor information. The material financial results and operational metrics warrant classification as a material financial event that does not fit the specific earnings_release category.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-22
Item 2.01
Kosmos Energy completed the sale of its 40.375% participating interest in the Ceiba Field and Okume Complex production assets in Block G offshore Equatorial Guinea to Panoro Energy ASA on June 16, 2026. The company received approximately $127 million in upfront cash consideration plus up to $39.5 million in contingent consideration. This is a material disposition of significant oil and gas assets that materially affects the company's asset base and future cash flows, triggering Item 2.01 disclosure requirements.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-22
EX-99.1
The news release announces the appointment of Edwin Shadeo as Acting Vice President, Investor Relations and Treasurer, effective immediately. While the release also mentions Emma Chapman's departure, the principal disclosed action is Shadeo's appointment to a named executive officer role. The appointment of a VP-level officer with treasury and investor relations responsibilities is material to a reasonable investor's assessment of the company's leadership and capital markets engagement.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-22
EX-99.1
This press release discloses the results of DHT's 2026 Annual Meeting of Shareholders held on June 18, 2026, including voting outcomes on two matters: (1) election of Jeremy Kramer as a Class I director with 69.93% of votes in favor, and (2) ratification of Ernst & Young AS as independent auditor with 99.86% of votes in favor. The disclosure directly matches the shareholder_vote_results taxonomy entry, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-22
Item 8.01
Cable One is commencing a material term loan exchange offer whereby MBI lenders exchange existing MBI Term Loans for a combination of cash, new first lien "first out" term loans (New FLFO Term Loans), and new first lien "second out" term loans (New FLSO Term Loans) under new credit facilities. This constitutes the creation of new direct financial obligations—the New CABO Term Loans—which are expected to be secured on a first-priority lien basis and will bear interest at specified rates with defined maturities. While the exchange involves refinancing existing debt, the core disclosure centers on the issuance of new debt instruments by Cable One, making debt_issuance the most appropriate classification.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 70%
filed 2026-06-22
Item 1.01
United Natural Foods entered into Amendment No. 5 to its Term Loan Agreement on June 18, 2026, repricing approximately $371 million in outstanding term debt by reducing the applicable margin over SOFR from 4.75% to 4.00%, thereby materially reducing the Company's borrowing costs.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-22
Item 5.02
Mary A. Tidlund resigned as a director effective June 30, 2026, with no disagreement cited. This is a straightforward director departure disclosure under Item 5.02. Director changes are material to investors as they affect board composition and governance, and the filing explicitly addresses the departure as the principal event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-06-22
EX-99.1
The exhibit discloses a material change involving a "further strengthening of its strategic partnership with Mitsubishi Materials" through an amended and restated investor rights agreement. Mitsubishi Materials will acquire 1.2 million common shares through open market purchases, extending the agreement until November 30, 2028, and returning Mitsubishi Materials' ownership to approximately 5%. This constitutes a material change of control or significant equity transaction that would affect a reasonable investor's assessment of the registrant's capital structure and strategic positioning.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-22
EX-99.1
This exhibit announces the closing of Sierra Madre's acquisition of First Majestic's Del Toro Silver Mine subsidiary for up to US$60M in cash and stock consideration. The transaction involves a share purchase agreement dated December 17, 2025, with closing announced June 22, 2026, including immediate payments of US$20M cash plus 10.87M shares, plus contingent milestone payments up to US$20M more. This is a material acquisition completion that would significantly affect investor assessment of both parties' asset portfolios and financial positions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-22
Item 5.07
Alaska Silver Corp. held its annual and special shareholders meeting on June 19, 2026, with shareholders approving five proposals: setting board size at six directors (99.77%), electing six directors including Christopher Marrs, Nathan Brewer, David Smallhouse, Kevin Nishi, Susan Mitchell, and Aaron Schutt (90.96%–95.49%), re-appointing Davidson & Company LLP as auditors (99.82%), approving the Long Term Incentive Plan (95.21%), and approving issuance of shares to insiders in debt settlement (98.98%), with 30.36% of shares represented at quorum.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-22
Item 1.01
HIVE amended and restated its Equity Distribution Agreement on June 16, 2026, authorizing the sale of up to US$300 million in common shares through an at-the-market offering, with $214.7 million in unused offering capacity as of the prospectus supplement filed June 17, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-22
Item 7.01
HIVE announced two material transactions: (1) a USD $220 million three-year sovereign AI GPU contract with Bell AI Fabric for Cohere Inc. involving deployment of NVIDIA Grace Blackwell infrastructure in Merritt, BC, and (2) the acquisition of the Big Boden 32 MW data center facility in Boden, Sweden from Bodens Utvecklings AB.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-22
Item 5.02
Lauren M. Tyler was elected to Centene's Board of Directors effective June 19, 2026, filling a newly created vacancy as the Board expanded from 9 to 10 members. She was assigned to the Audit Committee and Compensation and Talent Committee, bringing 30+ years of leadership experience including senior roles at JPMorgan Chase and current board service at Cencora and Guardian Life.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses results of an Annual Meeting of Stockholders held on June 17, 2026, with voting outcomes on four proposals: election of three directors, advisory vote on named executive officer compensation, approval of the 2026 Stock and Incentive Compensation Plan, and ratification of Grant Thornton LLP as independent auditor. Item 5.07 explicitly reports these shareholder vote results with detailed vote tallies, making this a classic shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
Shareholders approved a reverse stock split at a ratio of 1-for-2 to 1-for-5 by written consent of Goldeneye, the holder of 92.2% of voting power, in lieu of a special meeting of stockholders.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-22
Item 1.01
NeoGenomics completed the issuance of $316.25 million in aggregate principal amount of 0.75% Convertible Senior Notes due 2032 pursuant to an Indenture dated June 22, 2026, with up to 30,147,733 shares of common stock potentially issuable upon conversion at an initial conversion rate of 95.3288 shares per $1,000 principal. The offering was conducted as an unregistered private placement under Section 4(a)(2) and Rule 144A. The issuance represents a material creation of a direct financial obligation and a dilutive equity component, with concurrent debt repurchases and capped call terminations as ancillary refinancing mechanics.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-22
Item 8.01
Sky Quarry announced that its Eagle Springs/Foreland Refinery is entering the production phase with operations expected to commence in July 2026, representing a material transition from development and infrastructure repair to active commercial refining operations and a fundamental inflection point in the company's evolution.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of MetLife's June 16, 2026 annual shareholder meeting, including election of eleven directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed voting tallies for each director nominee and each proposal are the core content of the disclosure, making this a textbook shareholder vote results event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-06-22
EX-99.1
MDA Space has signed a definitive agreement to acquire 100% of Blue Canyon Technologies LLC for US$620 million (approximately C$874 million) in an all-cash transaction. The press release explicitly states this is a material acquisition that expands MDA's total addressable market, adds a profitable cash-generating business with 18-year history, and is expected to be accretive to Adjusted EBITDA and Adjusted EPS in 2027. The transaction is expected to close by end of 2026 subject to customary closing conditions and regulatory approvals.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-22
Item 7.01
This Item 7.01 disclosure updates the status of the previously announced merger between Paramount Skydance Corporation and Warner Bros. Discovery, Inc., specifically announcing that the Canadian Competition Act waiting period expired on June 20, 2026, and that the South African Competition Commission approved the Merger on June 19, 2026. These are material regulatory clearances advancing a transformative M&A transaction toward closing, making this an ma_activity event.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-22
EX-99.1
This exhibit is a press release announcing Bioceres' fiscal third quarter 2026 financial results (quarter ended March 31, 2026), including revenues of $39.4 million, net loss of $13.4 million, and Adjusted EBITDA of $(0.6) million. The document explicitly states "Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results" and includes detailed financial tables, management commentary, and reconciliations typical of a quarterly earnings release. Material to investors as it discloses significant operating losses and deteriorating financial performance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-22
Item 5.02
John W. Swann III, President of the Detection and Measurement Segment, informed the Company on June 18, 2026 of his decision to retire in January 2027. This is a clear executive departure—a named officer's announced retirement. The departure of a segment president is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-22
Item 8.01
The filing discloses a material stockholder derivative complaint (Thompson v. QXO, Inc., Case No. 2026-0757) filed in Delaware Chancery Court alleging breach of fiduciary duty by the board in connection with the proposed merger with TopBuild, seeking to enjoin the transaction and certify a class action. The disclosure also references multiple demand letters from purported stockholders alleging omissions in the proxy statement. While the litigation arises in the M&A context, the primary disclosed event is the material litigation itself—the complaint and demand letters—rather than the underlying merger activity, which was previously disclosed on April 18, 2026.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-06-22
BBVA reports execution of the third tranche of a share buyback program between 15–19 June 2026, with €791.6 million in shares purchased to date (54.22% of the maximum cash amount). Share repurchase programs are classified as returns of capital to shareholders under dividend_distribution. The material cash outlay and multi-tranche structure indicate this is a significant capital allocation decision material to investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-22
Item 8.01
uniQure announced preliminary Phase I/IIa clinical trial data for AMT-260 in refractory mesial temporal lobe epilepsy, showing that 3 of 6 patients achieved meaningful seizure reductions (79-100% decline) with no serious adverse events and favorable tolerability. This represents a material clinical development milestone for the company's gene therapy pipeline.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-22
Item 7.01
Traws Pharma announced its intention to resubmit an updated toxicology data package to the UK's MHRA for tivoxavir marboxil (TXM), a clinical-stage antiviral candidate, to enable a Phase 2a human influenza challenge study to proceed. This is a material regulatory and operational milestone for a clinical-stage biopharmaceutical company—the resubmission and anticipated MHRA approval are critical to advancing the company's lead program. While not a specific named event type, this disclosure centers on a material operational/regulatory development affecting the company's clinical pipeline and strategy.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-22
Item 8.01
The filing discloses a material stockholder class action lawsuit (Thompson v. QXO, Inc., Case No. 2026-0757, filed June 8, 2026) alleging breach of fiduciary duty by QXO board members in connection with the pending merger with TopBuild, seeking to enjoin the transaction and certify a class. The disclosure also references multiple stockholder demand letters making similar allegations. This is a material litigation event that could delay or prevent the merger's consummation, directly affecting the transaction's completion and the registrant's interests.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-22
Item 7.01
AbbVie announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share in cash, valuing the target at approximately $10.9 billion. The press release explicitly states "AbbVie will acquire all outstanding shares of Apogee" and describes this as a material acquisition that "complements AbbVie's existing immunology portfolio." This is a clear material acquisition event requiring disclosure under Item 1.01 or 2.01, disclosed here via Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 98%
filed 2026-06-22
EX-99.1
Fairfax completed an offering of C$300 million aggregate principal amount of 4.40% Senior Notes due 2036, bringing total outstanding notes of this series to C$700 million. This is a material creation of a direct financial obligation through debt issuance, disclosed in a news release announcing the completion of the offering. The company intends to use proceeds for general corporate purposes including refinancing, repayment, or acquisition opportunities.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-22
Item 8.01
The filing discloses three stockholder complaints (two in New York, one in Pennsylvania) and eleven demand letters challenging the adequacy of disclosures in the Definitive Proxy Statement regarding a proposed merger. The complaints seek to enjoin the merger and claim damages, representing material litigation that could affect the transaction's consummation and impose legal costs and business delays on the registrant.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-22
Item 8.01
Definium announced positive topline results from its Phase 3 Emerge study of DT120 ODT for major depressive disorder, meeting the primary endpoint with an 8.1-point placebo-adjusted MADRS improvement (p<0.0001) and demonstrating rapid, durable efficacy with a favorable safety profile. This represents a material clinical development milestone advancing the company's late-stage program toward potential FDA submission.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-22
Item 7.01
Booz Allen announced entry into a definitive agreement to acquire Ultra I&C Mission Solutions business for $720 million, a material acquisition of a defense technology business. The press release explicitly states the company "has entered into a definitive agreement" and describes the strategic rationale, expected financial performance (double-digit revenue growth, EBITDA margins above 20%), and expected closing timeline (Q2 FY2027). This is a classic Item 1.01 material acquisition disclosure.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-22
EX-99.1
GFL announces a proposed private offering of US$750 million in senior notes due 2031, creating a new direct financial obligation. The company explicitly states the Notes will be issued by a U.S. subsidiary and guaranteed by GFL and certain other subsidiaries. This is a material debt issuance that would affect a reasonable investor's assessment of the company's capital structure and leverage, particularly given the stated intent to maintain leverage in the mid-3.0x range and fund the SECURE Waste Infrastructure Corp. acquisition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-22
Manchester United announced the acquisition of a 25-acre site to build a new 100,000-seat stadium, described as a "major milestone" and "generational opportunity." This is a material strategic and operational development involving significant capital commitment and long-term business transformation. While not fitting the specific categories of M&A (which typically involve acquisition of another company), it represents a major operational and capital project that would affect a reasonable investor's assessment of the club's strategic direction and financial obligations.
View raw filing on EDGAR →
8-K
Restatement
confidence 98%
filed 2026-06-22
Item 4.02
The Audit Committee determined on June 17, 2026 that previously issued unaudited condensed consolidated financial statements for the three and nine months ended January 31, 2026 require restatement and should no longer be relied upon. The error involved a material goodwill impairment charge of $89.4 million related to the Space reporting unit, resulting in understated net loss by $87.3 million and overstated total assets by $89.4 million. The company also identified a material weakness in internal controls over financial reporting related to the goodwill impairment analysis.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-22
Item 5.02
Two directors, David Wodlinger and Henry Albers, resigned from the Board effective June 17, 2026. While the filing notes their resignations were not due to disagreement with management, the departure of two board members designated by a significant shareholder (Arlington Capital Partners) represents a material change in board composition and governance structure.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 85%
filed 2026-06-22
The filing announces an amendment to an existing long-term loan agreement with China Development Bank, revising the second tranche from RMB 1.23 billion to RMB 700 million and reducing the annual fixed interest rate from 4.98% to 4.30%. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the terms of a direct financial obligation and would be of interest to investors assessing the company's capital structure and financing costs.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Stone Point Credit Income Fund disclosed the unregistered sale of 1,013,220.501 common shares at NAV for $25,000,000 aggregate offering price, plus an additional 495,413.844 shares for $12,223,742, pursuant to subscription agreements with accredited investors under Section 4(a)(2) and Regulation D Rule 506. This is a classic dilutive private placement of equity securities exempt from registration, material to investors assessing the Fund's capital structure and the dilution to existing shareholders.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-22
The 6-K announces Capital Markets Board (CMB) approval on June 17, 2026 for Turkcell's issuance of domestic debt securities with a 15 billion TRY issue limit under private placement to qualified investors. This represents creation of a new direct financial obligation and is a material capital-raising event for the registrant.
View raw filing on EDGAR →
6-K
Exec departure
confidence 75%
filed 2026-06-22
The filing discloses the resignation of Ms. Enriqueta Felip Font from her position as a member of the Board of Directors and the Sustainability, Communication and Reputation Committee, effective June 19, 2026. While the filing also announces the appointment of a replacement director (Ms. Ester Masllorens Llinàs) and committee member (Mr. Pascal Ravery), the principal disclosed action is the departure of an existing board member. Board-level departures are material to investors' assessment of governance and continuity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Third Point Private Capital Partners completed an unregistered sale of 384,766 Class I common shares for $10,000,000 as of May 1, 2026, relying on Section 4(a)(2) and Regulations D and S exemptions to accredited investors and non-U.S. persons.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of ArriVent BioPharma's June 18, 2026 annual meeting of stockholders, including the election of three Class II directors (James Healy, John Hohneker, and Stuart Lutzker) and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing provides detailed vote tallies for each matter, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-22
Item 4.01
BPM LLP resigned as the Company's independent registered public accounting firm effective immediately on June 15, 2026. This is a clear auditor change under Item 4.01. The disclosure confirms no adverse opinions, disagreements, or reportable events, which mitigates concerns but does not change the materiality of the auditor departure itself—a change in certifying accountant is material to investors assessing financial reporting reliability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
Item 5.07 discloses the final voting results from Cypherpunk Technologies' 2026 Annual Meeting of Stockholders held on June 18, 2026. The section presents tabulated results for three matters: election of Class III directors (Will McEvoy and Nissim Mashiach), advisory approval of executive compensation, and ratification of EisnerAmper LLP as independent auditor. This is a textbook shareholder_vote_results disclosure.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-22
EX-99.1
This exhibit is an Eighth Supplemental Indenture dated June 19, 2026, providing for the issuance of $500 million in 5.55% Medium Term Notes (unsecured), Series 8, due June 19, 2031, by Brookfield Property Finance ULC. The document establishes the terms, conditions, and covenants governing this new debt issuance, including interest payment dates, redemption provisions, and change-of-control protections. This is a material creation of direct financial obligation under Item 2.03 of the 8-K taxonomy.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-22
Item 1.01
The filing discloses amendment of an existing $15 million loan agreement with Byline Bank, extending the maturity date from June 18, 2026 to June 18, 2028 and increasing tangible net worth requirements from $70 million to $80 million. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the registrant's direct financial obligations and extends the credit facility's term, which affects the company's capital structure and financial flexibility. The amendment also introduces a new default trigger tied to Excess Net Capital maintenance, which is material to investors assessing the company's financial stability.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-22
Item 5.02
Christopher Currier was appointed as Chief Accounting Officer (Principal Accounting Officer) effective June 16, 2026, promoted from Senior Vice President and Controller, succeeding Michael H. Schwerdtman's retirement from the role.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-22
Item 8.01
People Inc entered into a Voting Agreement on June 22, 2026 with Barry Diller, Diane von Furstenberg, and Alexander von Furstenberg, whereby these parties controlling approximately 46.4% of voting power agreed to vote their shares in excess of 48.5% in the same proportion as other shareholders, subject to independent committee approval for written consent actions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-22
Item 3.02
The Company issued 200,000 shares of Class B common stock to CEO/Chairman Huan Liu at $2.00 per share ($400,000 gross proceeds) in an unregistered private placement under Regulation S and Section 4(a)(2). The restricted securities issuance dilutes existing shareholders and represents a material insider transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
CrowdStrike held its Annual Meeting of Stockholders on June 17, 2026, with shareholders voting on four proposals: election of Class I directors (Johanna Flower and Denis J. O'Leary), ratification of PricewaterhouseCoopers LLP as independent auditor, approval of an amendment to limit officer liability under Delaware law, and an advisory vote on supermajority voting provisions. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →